Boston Sci launches hemostasis clip to control bleeding in GI endoscopy

Resolution 360 clip--Courtesy of Boston Scientific

Boston Scientific launched a new tool for hemostatic clipping, a technique used in some endoscopic procedures of the gastrointestinal system to stop and prevent bleeding.

There are more than 240,000 occurrences of gastrointestinal bleeding in the U.S. each year, the company said in a statement. These can stem from peptic ulcers, the removal of polyps during colonoscopy and diverticulosis of the colon. Globally, the mortality rate associated with upper and lower GI bleeding is 10%.

Boston Sci’s Resolution 360 Clip is built using a multiwire braided catheter, which allows the physician to rotate the device in small, controlled movements, the company said in the statement. This facilitates the accurate placement of the clip at a bleed site or potential bleed site in the gastrointestinal tract.


Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

"The Resolution 360 Clip gives me the unique advantage of controlling the movement and placement of the clip while also maneuvering the scope during the clipping procedure," said Dr. David Carr-Locke, chief of Mount Sinai’s division of digestive diseases, in the statement. "The ability to have complete control can help improves the accuracy of clip placement and the speed of the procedure particularly in complex cases."

The company is presenting the clip at the United European Gastroenterology Week and at the American College of Gastroenterology’s annual meeting this week.

Suggested Articles

By employing heart rate signals, physical activity and sleep quality, common Fitbit trackers may be able to predict the spread of the flu.

Nanox has raised $26 million to help fuel the development and commercialization of its Star Trek-inspired digital X-ray bed.

Oncology is clearly a major medical and societal issue, but one that sees too much focus from biopharmas at the expense of other killers.